These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21514150)

  • 81. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties.
    Wrobleski ST; Chen P; Hynes J; Lin S; Norris DJ; Pandit CR; Spergel S; Wu H; Tokarski JS; Chen X; Gillooly KM; Kiener PA; McIntyre KW; Patil-Koota V; Shuster DJ; Turk LA; Yang G; Leftheris K
    J Med Chem; 2003 May; 46(11):2110-6. PubMed ID: 12747783
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model.
    La Motta C; Sartini S; Salerno S; Simorini F; Taliani S; Marini AM; Da Settimo F; Marinelli L; Limongelli V; Novellino E
    J Med Chem; 2008 Jun; 51(11):3182-93. PubMed ID: 18452283
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Synthesis and anticonvulsant activity of 1,3-dihydro-5-phenyl-2H-pyrido[3,2-e]-1,4-diazepin-2-ones.
    Fiakpui CY; Knaus EE
    Drug Des Discov; 1993; 10(3):173-81. PubMed ID: 8268390
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Johnson TO; Hua Y; Luu HT; Sakata SK; Brown EL; Maldonado FC; Tuntland T; Lee CA; Fuhrman SA; Zalman LS; Patick AK; Matthews DA; Wu EY; Guo M; Borer BC; Nayyar NK; Moran T; Chen L; Rejto PA; Rose PW; Guzman MC; Dovalsantos EZ; Lee S; McGee K; Mohajeri M; Liese A; Tao J; Kosa MB; Liu B; Batugo MR; Gleeson JP; Wu ZP; Liu J; Meador JW; Ferre RA
    J Med Chem; 2003 Oct; 46(21):4572-85. PubMed ID: 14521419
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.
    DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Buchanan JL; Buckner WH; Cee VJ; Chai L; Deak HL; Epstein LF; Faust T; Gallant P; Geuns-Meyer SD; Gore A; Gu Y; Henkle B; Hodous BL; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; Masse CE; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; White RD; Zhao H; Zhu L; Zhu X
    J Med Chem; 2006 Sep; 49(19):5671-86. PubMed ID: 16970394
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
    Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist.
    Arbuckle W; Baker J; Barn D; Bingham M; Brown A; Buchanan K; Craighead M; Goodwin R; Goutcher S; Kiczun M; Lyons A; Milne R; Montgomery B; Napier S; Presland J; Sloan H; Turnbull Z; Wishart G
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4622-8. PubMed ID: 21700453
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 1.
    Matasi JJ; Brumfield S; Tulshian D; Czarnecki M; Greenlee W; Garlisi CG; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3805-8. PubMed ID: 21570840
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6.
    Tanaka A; Hattori K; Taniguchi K; Okitsu O; Tabuchi S; Nishio M; Nagakura Y; Maeda N; Murai H; Seki J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4861-4. PubMed ID: 16837197
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
    Zhao Z; Harrison ST; Schubert JW; Sanders JM; Polsky-Fisher S; Zhang NR; McLoughlin D; Gibson CR; Robinson RG; Sachs NA; Kandebo M; Yao L; Smith SM; Hutson PH; Wolkenberg SE; Barrow JC
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2952-2956. PubMed ID: 27133481
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives.
    Igawa H; Takahashi M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Kawata Y; Ashina S; Yamamoto S; Kundu M; Khamrai U; Hirabayashi H; Nakayama M; Nagisa Y; Kasai S; Maekawa T
    J Med Chem; 2016 Feb; 59(3):1116-39. PubMed ID: 26736071
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Design, synthesis and evaluation of novel 5-phenylpyridin-2(1H)-one derivatives as potent reversible Bruton's tyrosine kinase inhibitors.
    Zhao X; Xin M; Huang W; Ren Y; Jin Q; Tang F; Jiang H; Wang Y; Yang J; Mo S; Xiang H
    Bioorg Med Chem; 2015 Jan; 23(2):348-64. PubMed ID: 25515957
    [TBL] [Abstract][Full Text] [Related]  

  • 94. C6 modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption.
    Isaacs RC; Cutrona KJ; Newton CL; Sanderson PE; Solinsky MG; Baskin EP; Chen IW; Cooper CM; Cook JJ; Gardell SJ; Lewis SD; Lucas RJ; Lyle EA; Lynch JJ; Naylor-Olsen AM; Stranieri MT; Vastag K; Vacca JP
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1719-24. PubMed ID: 9873422
    [TBL] [Abstract][Full Text] [Related]  

  • 95. 6-aminoalkyloxazolo[4,5-b]pyridin-2(3H)-ones: synthesis and evaluation of antinoceptive activity.
    Savelon L; Bizot-Espiard JG; Caignard DH; Pfeiffer B; Renard P; Viaud MC; Guillaumet G
    Bioorg Med Chem; 1998 Nov; 6(11):1963-73. PubMed ID: 9881089
    [TBL] [Abstract][Full Text] [Related]  

  • 96. L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor.
    Sanderson PE; Cutrona KJ; Dorsey BD; Dyer DL; McDonough CM; Naylor-Olsen AM; Chen IW; Chen Z; Cook JJ; Gardell SJ; Krueger JA; Lewis SD; Lin JH; Lucas BJ; Lyle EA; Lynch JJ; Stranieri MT; Vastag K; Shafer JA; Vacca JP
    Bioorg Med Chem Lett; 1998 Apr; 8(7):817-22. PubMed ID: 9871547
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synthesis and evaluation of pyridazinone-phenethylamine derivatives as selective and orally bioavailable histamine H3 receptor antagonists with robust wake-promoting activity.
    Dandu RR; Gruner JA; Mathiasen JR; Aimone LD; Hostetler G; Benfield C; Bendesky RJ; Marcy VR; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6362-5. PubMed ID: 21944855
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Synthesis and structure-activity relationship of 5-substituent-2(1H)-pyridone derivatives as anti-fibrosis agents.
    Chen J; Lu MM; Liu B; Chen Z; Li QB; Tao LJ; Hu GY
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2300-2. PubMed ID: 22342629
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sulfoximine-directed ruthenium-catalyzed ortho-C-H alkenylation of (hetero)arenes: synthesis of EP3 receptor antagonist analogue.
    Yadav MR; Rit RK; Shankar M; Sahoo AK
    J Org Chem; 2014 Jul; 79(13):6123-34. PubMed ID: 24905413
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Identification of the first potent, selective and bioavailable PPARĪ± antagonist.
    Bravo Y; Baccei CS; Broadhead A; Bundey R; Chen A; Clark R; Correa L; Jacintho JD; Lorrain DS; Messmer D; Stebbins K; Prasit P; Stock N
    Bioorg Med Chem Lett; 2014 May; 24(10):2267-72. PubMed ID: 24745969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.